NCT00533208 MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED) Status COMPLETED Phase PHASE2
NCT00532935 MK0431A vs. Pioglitazone in Patients With Type 2 Diabetes Mellitus (0431A-066) Status COMPLETED Phase PHASE3
NCT00531115 Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer. Status TERMINATED Phase PHASE2
NCT00529659 A Study of the Safety and Efficacy of MK-0773 in Women With Sarcopenia (Loss of Muscle Mass)(MK-0773-005) Status COMPLETED Phase PHASE2
NCT00529373 A Study of MK-0822 in Postmenopausal Women With Osteoporosis to Assess Fracture Risk (MK-0822-018) Status TERMINATED Phase PHASE3
NCT00529243 Evaluating the Effect of CHanging EnfuvirtidE to Raltegravir in HIV Infected Subjects Status COMPLETED Phase PHASE3
NCT00529048 Quantification of the Incretin Effect in Healthy Subjects and Patients With Type 2 Diabetes Status COMPLETED Phase N/A
NCT00527943 Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736) Status TERMINATED Phase PHASE3
NCT00526474 Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (P04737) Status COMPLETED Phase PHASE3
NCT00525993 Efficacy and Safety of Etoricoxib in Acute Ankle Sprain: A Double-Blind Comparative Study Among 2 Treatments Protocols Status UNKNOWN Phase PHASE4
NCT00525733 Standard Antiretroviral v. Multi-class Therapy in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects (ADARC 2007-01) Status COMPLETED Phase NA
NCT00523211 Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5) Status COMPLETED Phase PHASE3
NCT00521924 Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1) (TERMINATED) Status TERMINATED Phase PHASE3
NCT00520598 Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001) Status COMPLETED Phase PHASE2
NCT00520234 Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU) Status COMPLETED Phase PHASE4
NCT00518739 MK2461 in Patients With Advanced Cancer (2461-001)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00518687 Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2) Status TERMINATED Phase PHASE2/PHASE3
NCT00518622 Study the Safety and Effectiveness of MK7009 in Hepatitis C Infected Patients (MK-7009-004)(COMPLETED) Status COMPLETED Phase PHASE1